Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,317 | 50,817 | 70,971 | 210,518 | 60,063 |
| Marketable Securities | 203,669 | 263,205 | 157,389 | 63,863 | N/A |
| Receivables | 25,347 | 8,175 | N/A | N/A | N/A |
| Inventories | 8,369 | 5,212 | N/A | N/A | N/A |
| TOTAL | $284,896 | $334,295 | $231,726 | $277,700 | $60,730 |
| Non-Current Assets | |||||
| PPE Net | 2,465 | 1,066 | 574 | 329 | 72 |
| Investments And Advances | 23,053 | 5,307 | 0 | 0 | 0 |
| Intangibles | 14,452 | 7,371 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,786 | 3,114 | 888 | 3,406 | 644 |
| TOTAL | $42,756 | $16,858 | $1,462 | $3,735 | $716 |
| Total Assets | $327,652 | $351,153 | $233,188 | $281,435 | $61,446 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 37,948 | 22,841 | 2,154 | 4,931 | 3,107 |
| Other current liabilities | 609 | 557 | N/A | 283 | 1,457 |
| TOTAL | $39,145 | $23,440 | $2,391 | $5,444 | $8,187 |
| Non-Current Liabilities | |||||
| Long Term Debt | 168,514 | 69,383 | N/A | N/A | 4,930 |
| Other Non-Current Liabilities | 5,735 | 1,532 | 37 | 3,105 | 3,559 |
| TOTAL | $174,249 | $70,915 | $37 | $3,105 | $8,489 |
| Total Liabilities | $213,394 | $94,355 | $2,428 | $8,549 | $16,676 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,297 | 98,120 | 96,502 | 94,403 | 35,143 |
| Common Shares | 10 | 10 | 10 | 9 | 3 |
| Retained earnings | -294,603 | -123,305 | -131,303 | -76,938 | -42,256 |
| Other shareholders' equity | 125 | 220 | 49 | 407 | 76,039 |
| TOTAL | $114,258 | $256,798 | $230,760 | $272,886 | $44,770 |
| Total Liabilities And Equity | $327,652 | $351,153 | $233,188 | $281,435 | $61,446 |